Reports

426 Results (Page 2 of 18)

China Markets Research Reports

Pharmaceuticals

China Immunosuppressant Drugs Market Analysis

China immunosuppressant drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The key factor fueling the growth of the immunosuppressants market is the rise in autoimmune illnesses like multiple sclerosis, alopecia areata, and arthritis. The market growth for immunosuppressants is also influenced by an increase in organ transplant procedures, such as kidney and liver transplants, which is brought on by an increase in the incidence of organ failure. Some of the major key players are Intas Pharmaceuticals Ltd. (Accord Healthcare Ltd.), Mylan N.V., AbbVie Inc., Sanofi S.A., GlaxoSmithKline Plc., Astellas Pharma Inc., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Pfizer Inc., Novartis International AG (Sandoz), Bristol-Myers Squibb Company.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Infection Control Supplies Market Analysis

China infection control supplies market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The key drivers driving the infection control sector are the expanding number of procedures that call for control measures to stop spreading and the increased prevalence of nosocomial infections. The key players in this market are 3M Company, Belimed AG, Halyard Health, Inc., Getinge Group, Advanced Sterilization Products, Matchana Group, Sterigenics International, MMM Group, Cantel Medical Corporation, STERIS Corporation.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Infectious Wound Care Management Market Analysis

China infectious wound care management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is expanding as a result of the ageing population, the prevalence of chronic diseases, and technologically advanced and lifestyle-related wound care products. The key players in this market are Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp, Medtronic, 3M, Derma Sciences Inc. (Integra LifeSciences), Medline Industries, Advancis Medical, B. Braun Melsungen AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Inflammatory Bowel Disease (IBD) Drugs Market Analysis

China Inflammatory Bowel Disease (IBD) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Numerous variables, including genetic predisposition, environmental triggers, and immune system disturbance, are to blame for the rising prevalence of ulcerative colitis and Crohn's disease. Most people who have ulcerative colitis or Crohn's disease have a family history of the condition. This will act as a driver for Inflammatory Bowel Disease (IBD) drugs market. AbbVie Inc. (U.S.) Takeda Pharmaceutical Company Limited (Tokyo) UCB S.A. (Belgium) Bausch Health Companies Inc. (Canada) Bristol-Myers Squibb Company (U.S.) Pfizer Inc. (U.S.) Celltrion Inc. (South Korea) Johnson & Johnson Services, Inc. (U.S.) are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Influenza Medications Market Analysis

China influenza medications market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Due to factors such an increase in influenza cases and increasing research and development for drug development initiatives, the global market for anti-flu medications is anticipated to rise. As a result of technological developments that generate a significant pipeline of novel pharmaceuticals, this industry may experience growth. Sanofi S.A, Lupin Limited, Teva Pharmaceutical Industries Ltd, Shionogi & Co. Ltd, Macleods Pharmaceutical Ltd, Alvogen Pvt. Ltd, AstraZaneca Plc, BioCryst Pharmaceuticals Inc, F. Hoffman La Roche Ltd, Novartis AG, Vitaris AG. Are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Influenza Vaccine Market Analysis

China influenza vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The government's increased emphasis on and support for the influenza vaccination is one of the major factors influencing the global market. Leading market players like CSL Limited, Sanofi, and GlaxoSmithKline plc are increasing their R&D expenditures in order to enhance their production capabilities and concentrate on the introduction of new vaccines, which is what is causing the industry to continue to grow. GlaxoSmithKline plc (U.K.), Sanofi (France), AstraZeneca (U.K.), CSL Limited (Australia), BIKEN Co., Ltd. (Japan), Abbott (U.S.), Sinovac (China) are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Inhalation Anesthesia Market Analysis

China inhalation anesthesia market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is expected to grow as a result of rising healthcare R&D spending and recent technological and scientific advancements. The market is anticipated to expand because to the rising demand for shorter hospital stays and more accessibility to healthcare services. Halocarbon Products Corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, AbbVie Inc are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Inhaled Nitric Oxide Market Analysis

China inhaled nitric oxide market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors driving the growth of this market are the rising prevalence of respiratory and other associated diseases and ongoing research and development activities. The key players in this market are Mallinckrodt, Linde plc., Air Liquide, BOC Limited, Bellerophon Therapeutics, Beyond Air Inc., Halma plc, VERO Biotech, Nu-Med Plus, Getinge AB, Merck KGaA, Genosys Informatics, Geno, and Perma Pure LLC.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Interactive Wound Dressing Market Analysis

China interactive wound dressing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology improvements, a growth in the prevalence of chronic wounds, and an increase in surgical procedures are the main factors driving the market for interactive wound dressings. Some of the key players in this market are Johnson & Johnson Medical N.V., Integra LifeSciences Corporation, B. Braun Melsungen AG, Cardinal Health, Medline Industries, Inc., Coloplast Pty Ltd, Medtronic, Beiersdorf AG, Mölnlycke Health Care AB, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Interferons Market Analysis

China interferons market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. It is anticipated that the development of novel drug delivery systems and the use of interferons in combination therapy will drive the market for interferons. The key players in this market are Roche, Merck & Co., Bristol-Myers Squibb, Biogen Inc., Bayer AG, Zydus Cadila, Novartis AG, Pfizer Inc., Biosidus, Synairgen, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Interstitial Cystitis Drugs Market Analysis

China interstitial cystitis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of interstitial cystitis and public knowledge of the ailment can be attributed for the market expansion. The key players in this market are Alvogen (CVC Capital Partners), Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd., Accord Healthcare, Avet Pharmaceuticals Inc. (Heritage Pharmaceuticals Inc.), Lannett, Viatris Inc. (Pfizer Inc.), Reckitt Benckiser Group PLC, VistaPharm, Inc, Aurobindo Pharma, Prestige Consumer Healthcare Inc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Intravenous Solutions Market Analysis

China intravenous solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of malnutrition, the quicker turnaround and higher efficacy associated with intravenous solution therapy, and the rise in the geriatric population all contribute to the growth of the intravenous solutions market. The key players in this market are Fresenius Kabi AG, Pfizer, Inc., Otsuka Pharmaceutical Co., Ltd., Baxter, B. Braun Melsungen AG, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, ICU Medical Inc., Grifols, S.A.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Irritable Bowel Syndrome Drugs Market Analysis

China irritable bowel syndrome drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased illness awareness, the expected timely availability of recently approved drugs, an enhanced payment system, and rising IBS prevalence are the main market drivers for IBS-D pharmaceuticals. The key players in this market are Allergan, Ironwood Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc., Bausch Health, Takeda Pharmaceutical Company Limited, AstraZeneca, Sebela Pharmaceuticals Inc., Synthetic Biologics, Inc., Astellas Pharma, Inc., and Ardelyx.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Isoflavones Market Analysis

China isoflavones drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is primarily driven by three factors: the growing elderly population, technological developments in the production of isoflavones, and the rising prevalence of cancer and other chronic disorders. The major key players in this market are Cargill, BASF, DSM, Shanghai Freemen, and ADM. Other key players include Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Avestia Pharma, NutraScience Labs, Tradichem S.L., Nutra Green Biotechnology.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Kidney Cancer Drugs Market Analysis

China kidney cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising consumer awareness, technical improvements, and the appeal of kidney and renal cancer drugs goods are all contributing reasons to the market's expansion. Some of the major key players in this market are Pfizer Inc (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Knee Cartilage Repair Market Analysis

China knee cartilage repair market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases. The major key players in this market are B. Braun Melsungen AG, Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Lactoferrin Market Analysis

China lactoferrin market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology advances that enable effective operational maintenance, efficient production, an extended product line, elegant design and packaging, and sales monitoring are key growth factors for the lactoferrin industry. The major key players in this market are Hilmar Cheese Company, Pharming Group NV, FrieslandCamina, Synlait Milk Ltd., Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., Glanbia plc, APS BioGroup, ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, InVitria, Milei GmbH, Ferrin-tech LLC.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Lipid Lowering Drugs Market Analysis

China lipid lowering drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increase in heart disease cases, higher awareness of the health risks associated with high cholesterol levels, and the availability of effective treatments are key factors driving the global market for lipid-lowering pharmaceuticals. The major key players in this market are Sanofi, Sun Pharmaceutical Industries Ltd., AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Merck & Co. Inc., Amgen Inc., and Dr. Reddy's.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Liver Cancer Drugs Market Analysis

China liver cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising incidence of liver cancer and the accessibility of novel medications are the two main drivers of market expansion over the forecast period. In the upcoming years, market expansion is anticipated to be fueled by increased investments in the research & development industry and the discovery of novel medicines. The major key players in this market are Bayer HealthCare Pharmaceuticals Inc. (Germany), Bristol-Myers & Squibb Company (US), Pfizer Inc. (US), Exelixis, Inc. (US), Merck Sharp & Dohme Corp. (US), Eisai Inc. (Japan), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland).

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Mammography Device Market Analysis

China mammography device market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The demand for mammography equipment is influenced by early cancer detection, cancer fear, and quality of life after a diagnosis. The major key players in this market are Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips N.V., Planmed Oy.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Medical Cannabis Drugs Market Analysis

China medical cannabis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally, there are more people with chronic illnesses, which will probably result in an increase in patients, and people are becoming more interested in living healthy lives. Additionally, it's projected that a rise in product approvals and increased R&D for cannabis-related medical devices will fuel market growth. The major key players in this market are Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, Curaleaf Holdings, Inc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Medical Electronics Market Analysis

China medical electronics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence and prevalence of chronic diseases, the growing elderly population, and the expanding use of machine vision are the few factors that will affect medical electronic market. The increased incidence of chronic diseases like cancer, neurological diseases, cardiovascular diseases, respiratory diseases, and others is the main factor driving market expansion. Some of the major key players in this market are Analog Devices, Inc., Texas Instruments Incorporated., Medtronic, STMicroelectronics, Mouser Electronics, Inc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Medical Imaging Market Analysis

China medical imaging market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Teaching hospitals and universities are projected to need more modern imaging modalities in order to train students in cutting-edge technology, which is anticipated to have a significant impact on market growth. The major key players in this market are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corp., Mindray Medical International, Esaote, Hologic, Inc., Samsung Medison Co., Ltd., Koning Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., Cubresa Inc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Medical Information Market Analysis

China medical information market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to grow due to the increase in demand for the creation of new drugs, the creation of technologically advanced healthcare solutions, and the ease with which information about healthcare products can be accessed. The major key players in this market are Accenture Plc, Change Healthcare Inc., Cognizant Technology Solutions Corp., Ergomed Plc, HCL Technologies Ltd., Infosys Ltd., IQVIA Holdings Inc., MakroCare, Parexel International Corp., ProPharma Group Holdings LLC.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Medical X-ray Market Analysis

China medical X-ray market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. One of the key factors driving the expansion of the medical X-ray market is the rising incidence of bone fractures. Other indirect market growth factors include increased personal disposable income, increasing rates of traffic accidents, and rising costs for R&D operations. Some of the major key players in this market are General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., Carestream Health., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up